Robbins Wendye's Form 4 filing
RAPT Therapeutics, Inc. (RAPT) · filed Aug 25, 2021
- Accession no.
- 0001593968-21-002027
- Filed
- Aug 25, 2021
- Trade date
- Aug 23-24, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $62.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robbins WendyeCIK 0001791244 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 | Common Stock | PPurchaseAcquired | +500 | $31.11 | +$15,555 | 500 | Indirect | |
| Aug 23, 2021 | Common Stock | PPurchaseAcquired | +500 | $31.50 | +$15,750 | 1,000 | Indirect | |
| Aug 23, 2021 | Common Stock | PPurchaseAcquired | +250 | $32.05 | +$8,012.5 | 1,250 | Indirect | |
| Aug 23, 2021 | Common Stock | PPurchaseAcquired | +225 | $31.00 | +$6,975 | 1,475 | Indirect | |
| Aug 24, 2021 | Common Stock | PPurchaseAcquired | +500 | $31.00 | +$15,500 | 1,975 | Indirect | |
| Aug 24, 2021 | Common Stock | PPurchaseAcquired | +25 | $30.81 | +$770.25 | 2,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.